MSLE
Satellos Bioscience Inc.
$8.98
+0.77 (+9.38%)
At close · Jul 8
Market Cap
$196.65M
Shares
20,831,190
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$8.98
Open$8.70
Day$8.66–9.60
52W$4.64–13.40
Avg vol 30d54K
Short int70K · 0.3% float · 1.9d
Short vol74%
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+20%
above
Price vs 50-day avg
+29%
above
RSI (14)
72
overbought
MACD trend
Positive
52-week position
50%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+48%
trailing
6-month return
+22%
trailing
YTD return
+53%
this year
Relative strength
+15%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $7 — 200d above 50d
Institutional flow
Accumulating
+31 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.34% of float · ▼ -8.6% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
31 holders — 13F breadth
Squeeze score
29
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
84%
annualized · 1-yr
Max drawdown
−57%
past year
ATR
7.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+20%
Bullish
Price vs 50-day avg
+29%
Bullish
RSI (14)
72
Bearish
MACD trend
Positive
Bullish
52-week position
50%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $7 › 200d $7 — 200d above 50d
Institutional flow
Accumulating
+31 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.34% of float · ▼ -8.6% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
31 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $5
Now $9 · 50%
52-wk high $13
vs 200-day avg +20%
vs 50-day avg +29%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MSLE
this stock
Satellos Bioscience Inc.
|
$196.65M | +52.7% | — | — | 0.3% |
|
ONC
BeOne Medicines Ltd.
|
$437.67B | -0.6% | +22179.2% | 890.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.01B | +9.9% | +46.2% | 29.5 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.03B | -14.0% | +20.8% | 16.3 | 3.2% |
|
ARGX
Argenx SE
|
$56.84B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MSLE | +15.5% | +47.7% | +22.3% | +15.5% | +52.7% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +15.7% | +46.9% | +14.8% | +15.7% | +43.4% |